Mondas PLC
06 April 2006
Mondas plc ('Mondas')
Brewin Dolphin Securities Ltd. selects Blue Curve
Brewin Dolphin Securities Ltd, the largest independent private client portfolio
manager and stockbroker in the UK, has today placed an order with Mondas for its
Blue Curve market leading research management software solution.
This initial contract has a minimum value of £220,000, the majority of which is
for is for a three year software licence and professional services, the revenue
from which is receivable and recognisable in the current financial year. The
remainder of the order is for support fees over the period.
Brewin Dolphin, which manages over £17 billion of funds on behalf of more than
100,000 clients, will initially install the software in its institutional
research department at Brewin Dolphin Securities Limited in Newcastle and its
Bell Lawrie division in Glasgow. The software will enable improvements in the
efficiency and effectiveness of its research department at a time when the
demands placed on it are increasing, not least from the increase in regulation.
In addition, Mondas will also assist in the rebranding of Brewin Dolphin and
Bell Lawrie research and in the integration of the software with existing
systems and data.
'This is a particularly pleasing win in light of our recent acquisition of Blue
Curve and our long and productive relationship with Brewin Dolphin.' says
Jarlath McGee, Chief Executive of Mondas PLC. 'This shows that that Mondas'
increased product offerings has appeal to our enlarged customer base and I look
forward to further such wins in the future.'
Mark Robertson, Director of Mondas' Financial Markets Division, commented, 'We
are proud to have been selected by Brewin Dolphin, a very important source of UK
company research and will ensure that the company is fully compliant with
current and future regulatory requirements laid down by the Financial Services
Authority.'
Simon Still, Chief Operating Officer of Brewin Dolphin Securities says, 'We
chose the Blue Curve Product, as it will enable us to efficiently streamline the
process and production of our Institutional Research Notes.'
6 April 2006
Mondas PLC 020 7392 1300
Jarlath McGee, Chief Executive
College Hill 020 7457 2020
Jamie Ramsay
Editor's note
Brewin Dolphin Securities Limited ('BDS') is the principal operating company of
Brewin Dolphin Holdings PLC which is listed on the London Stock Exchange. BDS is
authorised and regulated by the Financial Services Authority and is a member of
the London Stock Exchange.
BDS is the largest independent private client portfolio manager and stockbroker
in the UK. The Group manages over £17 billion of funds on behalf of more than
100,000 clients, and of this £6.9 billion is on a discretionary basis. BDS has
34 offices and is corporate adviser to 127 quoted companies.
The Group provides complete investment management for private investors,
charities and pension funds and trades as:
Brewin Dolphin in England, Wales and the Channel Islands
Bell Lawrie in Scotland and Northern Ireland
Hill Osborne in the East Midlands & East Anglia
Wise Speke in the North of England
Stocktrade is the BDS Execution-Only division. www.stocktrade.co.uk
www.brewindolphin.co.uk
Please see Press Centre section on www.brewindolphin.co.uk for details and
photos of all commentators and analysts throughout the BDS Group.
Mondas Blue Curve
Mondas Financial Markets Division is a provider of solutions to banks, brokers
and investment managers that improve complex business processes and reduce
operational risk. Blue Curve is the recognised leader in software applications
that improve the production and distribution of investment research, and is also
active in the growing investment management research and client reporting
markets. Blue Curve became part of the Mondas family of products when Mondas
plc acquired Blue Curve Limited in January 2006. www.mondas.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.